ProPhase Labs Inc (PRPH)
5.46
+0.15
(+2.82%)
USD |
NASDAQ |
May 03, 14:03
ProPhase Labs Cash and Short Term Investments (Quarterly): 4.736M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.736M |
| September 30, 2023 | 3.267M |
| June 30, 2023 | 9.104M |
| March 31, 2023 | 15.56M |
| December 31, 2022 | 17.44M |
| September 30, 2022 | 26.48M |
| June 30, 2022 | 27.50M |
| March 31, 2022 | 29.35M |
| December 31, 2021 | 17.26M |
| September 30, 2021 | 22.86M |
| June 30, 2021 | 36.25M |
| March 31, 2021 | 36.26M |
| December 31, 2020 | 8.455M |
| September 30, 2020 | 12.26M |
| June 30, 2020 | 5.876M |
| March 31, 2020 | 1.537M |
| December 31, 2019 | 1.36M |
| September 30, 2019 | 4.728M |
| June 30, 2019 | 5.734M |
| March 31, 2019 | 6.679M |
| December 31, 2018 | 8.241M |
| September 30, 2018 | 9.135M |
| June 30, 2018 | 10.44M |
| March 31, 2018 | 21.71M |
| December 31, 2017 | 21.94M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.54M |
| June 30, 2017 | 37.28M |
| March 31, 2017 | 42.80M |
| December 31, 2016 | 0.441M |
| September 30, 2016 | 0.375M |
| June 30, 2016 | 1.149M |
| March 31, 2016 | 2.457M |
| December 31, 2015 | 1.664M |
| September 30, 2015 | 1.336M |
| June 30, 2015 | 3.761M |
| March 31, 2015 | 5.021M |
| December 31, 2014 | 2.926M |
| September 30, 2014 | 4.953M |
| June 30, 2014 | 7.35M |
| March 31, 2014 | 5.519M |
| December 31, 2013 | 1.638M |
| September 30, 2013 | 0.751M |
| June 30, 2013 | 4.058M |
| March 31, 2013 | 4.536M |
| December 31, 2012 | 0.572M |
| September 30, 2012 | 1.815M |
| June 30, 2012 | 4.61M |
| March 31, 2012 | 6.268M |
| December 31, 2011 | 5.541M |
| September 30, 2011 | 4.616M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.36M
Minimum
Dec 2019
36.26M
Maximum
Mar 2021
15.05M
Average
12.26M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Fonar Corp | 53.26M |
| XWELL Inc | 23.05M |
| Applied DNA Sciences Inc | 3.359M |
| Veracyte Inc | 216.45M |
| OncoCyte Corp | 9.432M |